TX-MARY-KAY/GENDER-GAP
Below is a statement by Julia A. Simon, Chief Legal and Chief Diversity & Inclusion Officer, Mary Kay Inc., on the release of the 2022 World Economic Forum’s Global Gender Gap Report.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220831005218/en/
Julia Simon, Chief Legal Officer and Chief Diversity & Inclusion Officer (Photo Credit: Mary Kay Inc.)
According to a sobering finding from the World Economic Forum’s 2022 Global Gender Gap Report, gender parity is beyond reach in our lifetime. In fact, according to the report, it will take 132 years for gender equality to become a reality and 151 years to close the economic participation and opportunity gender gap. Not a single country from the 146 examined has reached parity.
That’s the bad news.
The good news? There’s still time to change all that. The 2022 findings have shaken me, but they have not deterred me. Nor should they deter you.
Gender equality is a prerequisite not only for human development—but sustainable economic growth. A rich body of data shows that without gender parity it is impossible to reduce poverty, attain food security, address climate impacts, or ensure a more peaceful and inclusive society. Gender parity isn’t a “nice to have.” It’s also not just a perk of developed nations. It is an essential requirement for all countries to develop and prosper.
To mitigate further backsliding, the structural barriers limiting women’s labor market participation, including their re-entry and retention in the workforce following COVID-19, must be addressed. Targeted policies which support women’s talent development in the industries of the future, and which accelerate their advancement to leadership and management positions, are also needed.
The private sector has a critical role to play in addressing gender gaps in the workplace and in developing the pipeline of women for leadership positions. As a company founded by a barrier-breaking businesswoman almost 60 years ago, this is personal to Mary Kay.
In 2019, Mary Kay signed the Women’s Empowerment Principles (WEPs) and in 2021 the company became a Commitment Maker to the Generation Equality Forum Action Coalitions to accelerate progress on gender equality to advance the Sustainable Development Goals.
Mary Kay is participating in the 2022-2023 UN Global Compact Target Gender Equality accelerator programme to continue the implementation of ambitious corporate targets for women’s representation and leadership in the company and in our supply chain. Leading by example and reflecting our belief in increased women’s inclusion, Mary Kay is putting our values and commitments into action:
Women’s Representation and Leadership at Mary Kay (Data from August 2022):
- 62% of our Global Workforce are Women
- 50% of our Executive Team are Women
- 53% of our Vice Presidents and above are Women
- 57% of our Directors and above are Women
- 59% of our Managers and above are Women
- 70% of our Market Leaders are Women
- 60% of our Leaders in our Top 10 Markets are Women
Gender-Responsive Procurement & Supplier Diversity at Mary Kay (U.S. only supply chain data from February 2021):
- 66% of our Procurement Team are Women
- 12% of our Indirect Suppliers are Women, Minority or Veteran-Owned
- 5% of our Direct Suppliers are Women, Minority or Veteran-Owned
Our 10-year Sustainability Strategy, titled Enriching Lives Today for a Sustainable Tomorrow, pursues a holistic approach to advancing gender equality and women’s empowerment with the following key commitments to achieve by 2030:
- Economically empower 5 million women worldwide
- Ensure access to education for 250,000 women and girls globally
- Provide over 10 million women worldwide with gender-based violence support services, and
- Develop a 10-year policy agenda to address women’s rights
Inspired by our mission as an entrepreneurship development company founded by a woman for women, we are committed to advancing women’s entrepreneurship and dismantling the barriers to women’s economic empowerment. We brought this vision to the United Nations in 2019 and, together with 6 UN agencies, we incepted the Women’s Entrepreneurship Accelerator (WEA) to create an enabling ecosystem for women entrepreneurs.
The time to act is now. Sitting on the sidelines and waiting 132 years is simply not an option. The Sustainable Development Impact Meeting on “Advancing Gender Equality”, which takes place in New York this month, is an opportunity for leaders from the public and private sector to identify tools and strategies to close the gender gap. We owe it to future generations to mobilize our efforts to make the transformative changes that are so badly needed for women and girls.
ABOUT MARY KAY
One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty company in 1963 with one goal: enriching women’s lives. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. As an entrepreneurship development company, Mary Kay is committed to empowering women on their journey through education, mentorship, advocacy, networking, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in enriching lives today for a sustainable tomorrow, partnering with organizations from around the world focusing on promoting business excellence, supporting cancer research, advancing gender equality, protecting survivors of domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram, and LinkedIn, or follow us on Twitter.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220831005218/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
